Beximco Pharma will market this product under the brand name Bexovid, initially in Bangladesh.
Pfizer's drug is protected by patents, but countries such as Bangladesh classified as least-developed countries (LDCs) by the United Nations can ignore such patents and make drugs more affordable in those markets. The TRIPS transition period for LDCs was extended till July 2034.
A great company to deal with, extremely reliable with a good range of products. Excellent product knowledge, great communication & customer service, fair prices and fast delivery.